Areas of responsibility

Creating long-term value

A customer-oriented corporate culture, strict cost management, and profit-oriented growth – these are the pillars on which the PHOENIX group’s growth strategy is built. Our ultimate goal is to create value for our company and our stakeholders on a sustainable basis. Market leadership and efficiency are therefore top priorities.

We want to grow organically as well as through acquisitions, and aim to consistently strengthen our position in pharmaceutical wholesale, pharmacies, and complementary services.

The essential issues for our own value creation are, in particular, adherence to quality standards, comprehensive availability of drugs, secure processing of customer data, and combatting counterfeit pharmaceuticals.

On course for success

The PHOENIX group continues to strengthen its market position as a leading pharmaceutical trader in Europe and is successfully developing its business. It is now one of the top 30 companies in Germany and one of the top 100 in Europe. In order to remain competitive and to continue its growth, the PHOENIX group also makes future-oriented investments. We have signed off on an extensive Europe-wide investment programme to which we committed €165.2 million in the fiscal year 2016/17 alone. These projects include the large logistics centre for pharmaceutical products in Scandinavia, two hubs, innovative picking technology, and a brand-new distribution centre.

Quality and safety

We work to the highest quality standards and provide our customers with a reliable and comprehensive service. This is supported by our effective quality management system, which includes compliance with good distribution practice (GDP) guidelines, as well as all legal requirements. Furthermore, the adoption of best practices across Europe complements these measures: the main focus is on the Warehouse Excellence programme, as part of an improvement process supported by our employees.

In the past year, we have launched the largest network for pharmacy cooperation programmes in Europe: PHOENIX Pharmacy Partnership. We are thus strengthening customer satisfaction through an improved range of services and competitive advantages for pharmacies. Through this network, we are offering more than 9,000 pharmacies in 15 countries and pharmaceutical manufacturers across Europe customised solutions to suit their individual needs.

In view of the interests of our customers and millions of patients, drug safety is very important to us. We are therefore involved in various associations and initiatives across Europe and are making preparations for the increasing requirements of the future.

Rising importance of data protection

Owing to the increasing legal requirements throughout Europe, the PHOENIX group is putting even greater focus on the issue of data protection. As a member of the German Association for Data Protection and Data Security (GDD), we regularly exchange information on this matter with other companies. The Head of Data Protection, in collaboration with the data protection officers in the subsidiaries, is responsible for monitoring the fulfilment of all data protection requirements.

One of the challenges that we currently face is the introduction of the European General Data Protection Regulation, which will come into force in May 2018. In preparation, we have put together a working group consisting of data protection officers and employees from Group IT. We are aiming to introduce group-wide internal data protection guidelines by May 2018 at the latest.

In order to emphasise the issue of data protection throughout the entire organisation, we need our employees to obtain a high level of specialist qualifications. In Germany, it is our express goal that all staff will have received the appropriate training by the end of the fiscal year 2017/18.

Value creation

Would you like to learn more about our latest developments in value creation? Read the chapter in our latest CSR Report.

Read chapter